AMARC Angst: Has FDA put pharma Facebook "Likes" in the crosshairs?
What the agency writes in a recent warning letter to a dietary supplement firm is instructive with regard to "Liking" ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.